Skip to main content
logo
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
2,025.60
-27.00 (-1.32%)
Aug 6, 2025, 3:29 PM IST

Altus Power Revenue

In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 134.35B INR with 6.25% growth. Glenmark Pharmaceuticals had revenue of 32.68B in the quarter ending March 31, 2025, a decrease of -16.11%.

Revenue
134.35B
Revenue Growth
+6.25%
P/S Ratio
4.25
Revenue / Employee
8.96M
Employees
14,989
Market Cap
571.63B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025134.35B7.90B6.25%
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories93.60B
Cipla274.80B
Mankind Pharma129.10B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Fortis Healthcare77.86B
Aurobindo Pharma320.25B
Revenue Rankings

Glenmark Pharmaceuticals News

More News